RE: Just the start23 Jul 2024 17:28
It is just the start but let's have an early Boom.
In August 2022, an examiner from the EPO, acting as the ISA, issued a search report and written opinion, confirming the pharmaceutical composition and method of use claims for all of Awakn's lead compounds to be both novel and inventive.